Britannia Pharmaceuticals Ltd.

Quick facts

Phase 2 pipeline

• Apomorphine Nasal Powder · Neurology
  Apomorphine works by stimulating dopamine receptors in the brain, which helps to improve motor function in people with Parkinson's disease.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Britannia Pharmaceuticals Ltd. portfolio CI brief
• Britannia Pharmaceuticals Ltd. pipeline updates RSS